Prehypertension is associated with significant damage to the coronary vasculature and increased rates of adverse cardiovascular events. Circulating endothelial progenitor cells (EPCs) are critical to vascular repair and the formation of new blood vessels. We tested the hypothesis that prehypertension is associated with EPC dysfunction. Peripheral blood samples were collected from 83 middle-aged and older adults (51 male and 32 female): 40 normotensive subjects (age 53 ± 2 years; BP 111/74 ± 1/1 mm Hg) and 43 prehypertensive subjects (age 54±2 years; 128/77±1/1 mm Hg). EPCs were isolated from peripheral blood, and EPC colony-forming capacity (colony-forming unit (CFU) assay), migratory activity (Boyden chamber) and apoptotic susceptibility (active caspase-3 concentrations) were determined. There were no significant differences in the number of EPC CFUs (10 ± 2 vs 9 ± 1), EPC migration (1165 ± 82 vs 1120 ± 84 fluorescent units) or active intracellular caspase-3 concentrations (2.7 ± 0.3 vs 2.3 ± 0.2 ng ml
Introduction
Approximately 30% of the adult population in the United States is prehypertensive, defined as systolic blood pressure (BP) between 120 and 139 mm Hg or diastolic BP between 80 and 89 mm Hg. 1 A primary concern in adults with prehypertension is a heightened cardiovascular disease risk. Indeed, the multivariate-adjusted relative risk of an adverse cardiovascular event, such as myocardial infarction, is 3.5 times higher in individuals with prehypertension compared with their normotensive counterparts of similar age. 2 Although the precise mechanisms underlying elevated cardiovascular risk associated with prehypertension are not fully understood, moderate elevations in BP may damage vascular endothelium and disrupt endothelial cell repair. Prehypertensive individuals show significant target-organ damage of the coronary 3 and renal circulation. 4 Circulating endothelial progenitor cells (EPCs) have the capacity to migrate to local sites of ischaemia and endothelial damage, resist cellular apoptosis, secrete potent angiogenic growth factors and participate in vascular repair and neovascularization. 5, 6 Moreover, systemic transplantation of ex vivo-expanded EPCs into the coronary artery can rescue ischaemic tissue and significantly improve coronary function in patients with myocardial infarction. 7 Declines in EPC bioavailability and function, including reduced colony-forming capacity and migratory activity, have been linked with accelerated atherosclerotic disease progression, poor cardiovascular disease prognosis and adverse outcomes. [8] [9] [10] Thus, a potential mechanism contributing to the heightened cardiovascular risk with prehypertension may be abnormalities in EPC function.
Accordingly, the experimental aim of the present study was to determine whether prehypertension is associated with EPC dysfunction. To address this aim, we isolated EPCs from healthy normotensive and prehypertensive adults and assessed EPC colony-forming capacity, migratory activity and apoptotic susceptibility.
Materials and methods

Subjects
A total of 83 subjects across the adult age range were studied: 40 normotensive subjects (systolic BPo120 mm Hg and diastolic BPo80 mm Hg) and 43 prehypertensive subjects (systolic BP 120-139 mm Hg and/or diastolic BP 80-89 mm Hg). Subjects reported for testing procedures between 0800 hours and 1100 hours after an overnight fast. Prehypertension was defined according to the Joint National Committee (JNC-7) guidelines. 11 All subjects were non-obese and free of overt cardiovascular and metabolic disease, as assessed by medical history, physical examination and fasting blood chemistries. Men over the age of 40 years were further evaluated for clinical evidence of coronary artery disease using electrocardiograms and BP monitoring at rest and during incremental exercise performed to exhaustion. All the women were at least 1 year postmenopausal (mean: 7 ± 1 years) and had never taken or had discontinued the use of hormone replacement therapy at least 1 year before the start of the study. None of the subjects smoked, were taking medications or performed regular physical exercise for at least 6 months before the start of the study. Before participation, all of the subjects had the research study and its potential risks and benefits explained fully before providing a written informed consent according to the guidelines of the University of Colorado at Boulder. All experiments conformed to Declaration of Helsinki.
Body composition
Body mass was measured to the nearest 0.1 kg using a medical beam balance. Percent body fat was determined by dual-energy X-ray absorptiometry (Lunar, Madison, WI, USA). Body mass index was calculated as weight in kilograms divided by height in metres squared. Minimal waist circumference was measured according to published guidelines. 12 Treadmill exercise test To assess aerobic fitness, subjects performed incremental treadmill exercise using a modified Balke protocol. Maximal oxygen consumption (VO 2 max) was measured using online computer-assisted opencircuit spirometry, as previously described. 13 
Metabolic measurements
Fasting plasma lipid and lipoprotein, glucose and insulin concentrations were determined using conventional methods by the clinical laboratory affiliated with the University of Colorado Clinical and Translational Research Center.
EPC isolation and characterization
As described previously, 14 circulating putative EPCs were isolated from peripheral blood by Ficoll density-gradient centrifugation (Histopaque 1077, Sigma Aldrich, St Louis, MO, USA), washed and resuspended in growth medium (Medium 199; Gibco, Grand Island, NY, USA) supplemented with 20% fetal calf serum (Gibco), penicillin (100 U ml À1 , Gibco) and streptomycin (100 mg ml À1 , Gibco). Endothelial phenotype of these cells was confirmed by immunofluorescent staining for the uptake of DiI-ac-LDL (Biomedical Technologies Inc Stoughton, MA, USA) and expression of VE-cadherin, von Willebrand factor, CD31 and vascular endothelial growth factor receptor-2 (Carlsbad, CA, USA).
EPC colony-forming assay
Endothelial progenitor cell colony-forming capacity was determined as previously described by our laboratory. 15 Briefly, freshly isolated mononuclear cells were plated on six-well plates coated with human fibronectin (BD Biosciences, San Jose, CA, USA) for 48 h at 37 1C. Thereafter, non-adherent cells were collected, and 5 Â 10 5 cells were re-plated onto 24-well fibronectin-coated plates (BD Biosciences). Growth medium was changed every 3 days, and the EPC colony-forming units (CFUs) were counted manually in four random wells on day 7 by two independent investigators blinded to sample identification. Only CFUs consisting of multiple thin, flat cells emanating from a central cluster of rounded cells were counted.
Migration assay
Endothelial progenitor cell migratory capacity was measured using a modified Boyden chamber. 15 Non-adherent cells (4 Â 10 5 ) were resuspended in serum-free culture medium (Medium 199, Gibco) and loaded in the upper compartment of a 24-well modified Boyden chamber coated with fibronectin (FluoroBlok, BD Biosciences). The upper chamber was placed into the lower chamber containing culture medium supplemented with vascular endothelial growth factor (2 ng ml À1 ) and incubated for 22 h at 37 1C. After incubation, cells were labelled with calcein AM (Molecular Probes, Eugene, OR, USA) and relative fluorescent units (RFUs) of migrated cells were determined in triplicate.
Determination of caspase-3 activation
Activation of caspase-3 was induced in EPCs by incubating with staurosporine (1 mmol l À1 ) for 3 h at 37 1C. After staurosporine stimulation, cells were washed in phosphate-buffered saline and incubated with 10 mmol biotin-ZVKD-fmk inhibitor for 1 h at 37 1C. Thereafter, cells were washed and lysed with extraction buffer at a concentration of 1 Â 10 7 cells per ml. The concentration of active caspase-3 in the supernatant was determined by enzyme immunoassay (R&D Systems, Minneapolis, MN, USA).
Statistical analysis
Differences in subject baseline characteristics and the primary outcome variables were determined by analysis of variance (ANOVA). Relations between variables of interest were determined by linear regression analysis. There were no significant gender interactions in any of the primary outcome variables; therefore, the data were pooled and presented together. Data are reported as mean ± s.e.m. Statistical significance was set at Po0.05.
Results
Selected subject characteristics are presented in Table 1 . Although most anthropometric characteristics were similar between the groups, percentage body fat was significantly lower in the prehypertensive adults. By design, both systolic and diastolic BP were higher (Po0.05) in the prehypertensive group compared with the normotensive controls. There were no differences between the groups in plasma lipid and lipoprotein, glucose and insulin concentrations.
There were no significant differences in the number of EPC CFUs between the normotensive (10±2) and prehypertensive (9±1) groups. EPC migratory activity was also similar between the normotensive (1165 ± 82 RFU) and prehypertensive (1120±84 RFU) adults. In addition, basal (0.3±0.04 vs 0.3 ± 0.03 ng ml À1 ) and stimulated (2.7 ± 0.3 vs 2.3 ± 0.2 ng ml À1 ) intracellular active caspase-3 concentrations were not different between the normotensive and prehypertensive adults. However, when the prehypertensive group was stratified into low prehypertension (n ¼ 27; 120-129 mm Hg systolic BP or 80-84 mm Hg diastolic BP) and high prehypertension (n ¼ 16; 130-139 mm Hg systolic BP or 85-89 mm Hg diastolic BP), differences in EPC colony-forming capacity emerged. EPCs isolated from adults with high prehypertension produced B65% (4 ± 1; Po0.05) fewer CFUs compared with both low prehypertensive (12 ± 2) and normotensive subjects (Figure 1 ). There was a significant correlation (r ¼
À1
) between the low and high prehypertensive groups (Figure 2 ).
Discussion
The primary new findings of the present study are that (1) the ability of EPCs to form colonies is impaired in prehypertensive adults with systolic BP greater than 130 mm Hg and (2) prehypertension is not associated with diminished EPC migratory capacity or increased apoptotic susceptibility. To our knowledge, this is the first study to determine the influence of prehypertension on important functional characteristics of EPCs.
Numerous epidemiological studies have reported that the risk of coronary artery disease and major vascular events progressively increases with incremental elevations in BP, independent of traditional risk factors, even before the onset of overt hypertension (BPX140/90 mm Hg). 16, 17 For example, in a large cohort of the Framingham Heart Study, Vasan et al. 18 showed a significant stepwise increase in the relative risk of myocardial infarction, stroke and heart failure in subjects with high prehypertension (systolic BP4130 mm Hg) compared with Impairments in EPC function have been reported in hypertensive adults and may contribute aetiologically to the increased cardiovascular risk in this group. 9, 19 EPC colony formation is a distinctive pattern of cell arrangement that manifests after B1 week of culture. EPC colony-forming capacity is related to flow-mediated brachial artery vasodilation and cardiovascular risk, and is a better predictor of endothelial dysfunction than conventional cardiovascular risk factors. 20 In addition, the number of CFUs can predict the extent of multivessel coronary artery disease in middle-aged adults. For example, it has been suggested that for every 10 EPC CFU increase, the risk of multivessel coronary artery disease declines by 20%. 8 In the present study, EPC colony-forming capacity was significantly lower (B65%) in prehypertensive adults with systolic BPX130 mm Hg. In contrast, no differences in the number of EPC CFUs were found between the low prehypertensive (systolic BP 120-129 mm Hg) and normotensive adults. In addition, we observed a modest, but significant, inverse relation (r ¼ À0.22) between the number of EPC CFUs and systolic BP. Although a previous investigation found no difference in EPC colony formation between patients with essential hypertension and non-hypertensive subjects, the control group included prehypertensive individuals, 21 indicating that potential differences in EPC function between true normotensive controls and prehypertensive/hypertensive subjects may have been obscured. Indeed, the mean colony number of our high prehypertensive subjects is similar to the control subjects in that study (4 ± 1 vs 3 ± 1). Of note, our findings support the notion that the negative influence of prehypertension on EPC function is a consequence of elevated systolic rather than diastolic BP. Moreover, it is consistent with many prospective observational studies showing that the deleterious cardiovascular consequences associated with prehypertension, for example, increased risk of myocardial infarction and ischaemic stroke, are attributable to elevations in systolic BP. 22, 23 In contrast to colony formation, EPC migration was remarkably similar in the normotensive and prehypertensive groups, even when stratified into low and high prehypertension. The ability of EPCs to migrate is essential for homing to local sites of vascular injury and promoting revascularization and new blood vessel formation. 24 For example, in patients with myocardial infarction, the reduction in infarct size after transplantation of ex vivoexpanded progenitor cells into the coronary artery is determined by their ability to migrate to the ischaemic tissue. 25 At sites of vascular trauma and injury, VEGF and other angiogenic cytokines such as stromal cell-derived factor-1 and granulocyte colony stimulating factors are released to recruit circulating EPCs to areas of tissue repair. 26 Impaired migration of EPCs may limit the number of cells available at injured areas of vascular tissue, thus attenuating their regenerative capacity. The results of the present study indicate that prehypertension does not negatively influence the capacity of EPCs to migrate. Interestingly, Vasa et al. 9 showed that essential hypertension is an independent predictor of impaired EPC migration. Thus, it seems that a BP threshold exists with respect to impaired migratory function of EPCs.
The ability of EPCs to resist apoptosis is also an important functional characteristic, as continual activation and recruitment of EPCs to the sites of vascular damage can lead to enhanced apoptosis and attrition. 5 Greater apoptosis and enhanced susceptibility to apoptotic factors could attenuate vascular repair and contribute to endothelial dysfunction and atherogenesis. Activation of caspase-3, the so-called 'executioner molecule' of apoptosis, represents cellular commitment to programmed cell death. However, we did not observe any differences in intracellular caspase-3 concentrations stimulated by staurosporine between the prehypertensive and normotensive adults.
A potential mechanism underlying reduced EPC colony formation with prehypertension is oxidative stress and/or increased angiotensin II activity. Prehypertension is associated with a pro-oxidant environment and elevations in angiotensin II. 27, 28 Furthermore, both oxidative stress and angiotensin II have been shown to impair EPC function. [29] [30] [31] For example, treatment of ex vivo-expanded EPCs with angiotensin II was shown to accelerate cellular senescence, inactivate telomerase and impair EPC proliferation through increased intracellular oxidative damage, whereas pre-treatment with the angiotensin type-I receptor antagonist, valsartan, inhibited these effects. 30 Thus, it is possible that elevated angiotensin II activity with prehypertension may increase intracellular oxidative stress and accelerate telomerase inactivation, which may in turn reduce EPC colony formation. This possibility, however, requires further investigation.
There are a number of experimental considerations of the present study that should be mentioned. Firstly, there is currently no clear consensus on the most appropriate criteria for the isolation, culture or quantification of EPCs, creating ambiguity when comparing and interpreting studies involving EPCs. In the present investigation, we isolated a putative EPC cell population from circulating peripheral blood mononuclear cells and then employed a short culture period to eliminate mature, adherent cell types. The remaining cells exhibit several endothelial phenotypic characteristics, including lowdensity lipoprotein uptake and expression of lectin, vascular endothelial growth factor receptor-2 and CD31. 32, 33 It has been consistently documented that these cells participate in vasculogenesis and vascular repair, [33] [34] [35] and are related to both endothelial dysfunction and cardiovascular risk. 10, 20 Secondly, as with all cross-sectional experimental designs, we must acknowledge the possibility that genetic and/ or lifestyle behaviours influenced our results. Similarly, numerous pathological, pharmacological and physiological factors have been reported to influence EPC number and function. We attempted to minimize these potential confounds by studying thoroughly screened adults who were free of overt disease, were non-medicated, non-smokers and were not physically active.
In conclusion, the results of the present study suggest that, by and large, EPC dysfunction commonly observed with hypertension is not present in the prehypertensive state. Prehypertension is associated with reduced EPC colony-forming capacity, but this impairment is limited to the prehypertensive state with systolic BPX130 mm Hg. However, prehypertension does not exert a negative influence on EPC migration or susceptibility to apoptosis. Thus, EPC dysfunction does not seem to be a major contributor to the increased cardiovascular risk associated with prehypertension.
What is known about this topic K Prehypertension is associated with an increased risk of coronary artery disease and acute vascular events, such as myocardial infarction and stroke. K Endothelial injury and dysfunction are thought to contribute to cardiovascular risk in individuals with prehypertension. K Impairments in endothelial progenitor cell (EPC) function, including reduced colony-forming capacity and migratory activity, have been linked to endothelial dysfunction, atherosclerotic disease progression and cardiovascular events.
What this study adds K The capacity of EPCs to form colonies is impaired in prehypertensive adults with systolic blood pressure greater than 130 mm Hg. K Prehypertension is not associated with diminished EPC migratory activity or enhanced susceptibility to apoptosis.
